Cargando…
The Vitamin D Receptor in Osteoblast-Lineage Cells Is Essential for the Proresorptive Activity of 1α,25(OH)(2)D(3) In Vivo
We previously reported that daily administration of a pharmacological dose of eldecalcitol, an analog of 1α,25-dihydroxyvitamin D(3) [1α,25(OH)(2)D(3)], increased bone mass by suppressing bone resorption. These antiresorptive effects were found to be mediated by the vitamin D receptor (VDR) in osteo...
Autores principales: | Mori, Tomoki, Horibe, Kanji, Koide, Masanori, Uehara, Shunsuke, Yamamoto, Yoko, Kato, Shigeaki, Yasuda, Hisataka, Takahashi, Naoyuki, Udagawa, Nobuyuki, Nakamichi, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575053/ https://www.ncbi.nlm.nih.gov/pubmed/32987399 http://dx.doi.org/10.1210/endocr/bqaa178 |
Ejemplares similares
-
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
por: Murakami, Kohei, et al.
Publicado: (2017) -
Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020) -
Arctigenin Inhibits Osteoclast Differentiation and Function by Suppressing Both Calcineurin-Dependent and Osteoblastic Cell-Dependent NFATc1 Pathways
por: Yamashita, Teruhito, et al.
Publicado: (2014) -
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis
por: Ozaki, Yuki, et al.
Publicado: (2017) -
Noncanonical Wnt5a enhances Wnt/β-catenin signaling during osteoblastogenesis
por: Okamoto, Masanori, et al.
Publicado: (2014)